Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis.

Source:http://linkedlifedata.com/resource/pubmed/id/9834134

J. Immunol. 1998 Dec 1 161 11 6421-6

Download in:

View as

General Info

PMID
9834134